Table 1.
Baseline data of patients assigned to the three categorized groups
| Group 1 | Group 2 | Group 3 | p value | Test | |
|---|---|---|---|---|---|
| Number (n) | 583 | 702 | 474 | ||
| Age (mean, SD) | 55.4 ± 18.6 | 56.0 ± 14.5 | 53.5 ± 18.3 | 0.04 | ANOVA |
| Gender (Women) | 289 (49.6%) | 397 (56.6%) | 269 (56.8%) | 0.02 | Chi square |
|
Extent of resection Biopsy STR GTR |
80 (13.7%) 75 (12.9%) 428 (73.4%) |
44 (6.3%) 80 (11.4%) 577 (82.2%) |
19 (3.9%) 84 (17.1%) 387 (78.7%) |
< 0.001 | Chi square |
| Duration of Surgery (mean,SD) | 229.9 ± 132.1 | 286.2 ± 126.4 | 273.3 ± 120.6 | < 0.001 | ANOVA |
| Thrombosis | 10 (1.7%) | 159 (22.6%) | 21 (4.4%) | < 0.001 | Chi square |
|
Thrombosis type DVT Muscle vein Central venous line |
1 (10.0%) 3 (30.0%) 1 (10.0%) |
116 (73.0%) 57 (35.8%) 45 (28.3%) |
14 (66.7%) 5 (23.8%) 2 (9.5%) |
0.003 | Chi square |
| PE | 3 (0.5%) | 36 (5.1%) | 4 (0.8%) | < 0.001 | Chi square |
|
Positioning Supine Prone Seated Half side |
475 (81.5%) 28 (4.8%) 54 (9.3%) 26 (4.5%) |
591 (84.2%) 41 (5.8%) 31 (4.4%) 39 (5.6%) |
343 (72.4%) 27 (5.7%) 26 (5.5%) 78 (16.5%) |
< 0.001 | Chi square |
|
Tumor entities WHO 1 WHO 2 WHO 3 WHO 4 Metastasis Other |
276 (47.3%) 34 (5.8%) 36 (6.2%) 106 (18.2%) 82 (14.1%) 49 (8.4%) |
384 (54.7%) 48 (6.8%) 24 (3.4%) 125 (17.8%) 88 (12.5%) 33 (4.7%) |
261 (55.1%) 24 (5.1%) 3 (0.6%) 61 (12.9%) 84 (17.7%) 41 (8.6%) |
< 0.001 | Chi square |